View in EDS HTML Full Text PDF Full Text

Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects.

Saved in:
Bibliographic Details
Title: Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects.
Authors: Sishc BJ; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ramnarain D; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Shang Z; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Alves EM; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Bloom DA; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hughes K; Department of Veterinary Medicine, Colorado State University, Ft Collins, CO, United States., Saha D; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Riley DP; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Keene JL; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Beardsley RA; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Story MD; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Feb 20; Vol. 16, pp. 1761003. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41800061
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sishc+BJ%22">Sishc BJ</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ramnarain+D%22">Ramnarain D</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Shang+Z%22">Shang Z</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Alves+EM%22">Alves EM</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Bloom+DA%22">Bloom DA</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Hughes+K%22">Hughes K</searchLink>; Department of Veterinary Medicine, Colorado State University, Ft Collins, CO, United States.<br /><searchLink fieldCode="AU" term="%22Saha+D%22">Saha D</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Riley+DP%22">Riley DP</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States.<br /><searchLink fieldCode="AU" term="%22Keene+JL%22">Keene JL</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States.<br /><searchLink fieldCode="AU" term="%22Beardsley+RA%22">Beardsley RA</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States.<br /><searchLink fieldCode="AU" term="%22Story+MD%22">Story MD</searchLink>; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Feb 20; Vol. 16, pp. 1761003. <i>Date of Electronic Publication: </i>2026 Feb 20 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41800061
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1761003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1761003
    Titles:
      – TitleFull: Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sishc BJ
      – PersonEntity:
          Name:
            NameFull: Ramnarain D
      – PersonEntity:
          Name:
            NameFull: Shang Z
      – PersonEntity:
          Name:
            NameFull: Alves EM
      – PersonEntity:
          Name:
            NameFull: Bloom DA
      – PersonEntity:
          Name:
            NameFull: Hughes K
      – PersonEntity:
          Name:
            NameFull: Saha D
      – PersonEntity:
          Name:
            NameFull: Riley DP
      – PersonEntity:
          Name:
            NameFull: Keene JL
      – PersonEntity:
          Name:
            NameFull: Beardsley RA
      – PersonEntity:
          Name:
            NameFull: Story MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2026 Feb 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1